Get started
Author

Marco R. de Groot

Observed names: M Groot, M R de Groot, M. R. De Groot, M. R. de Groot, M.R de Groot, M.R. de Groot, MARC ROBERT DE GROOT, MARCO R. DE GROOT, Marco R De Groot, Marco R de Groot, Marco R. De Groot
Observed institutions: University Medical Center Groningen, The University of Texas MD Anderson Cancer Center, University of Groningen, Université Paris Cité, University of the Free State, Leiden University Medical Center, Catharina Ziekenhuis, Medisch Spectrum Twente, Amsterdam UMC Location University of Amsterdam, Centre Hospitalier Universitaire de Bordeaux, LMU Klinikum, Centre Hospitalier Universitaire de Toulouse, Sanquin, Universitätsklinikum Erlangen, Institut universitaire du cancer de Toulouse Oncopole, Universitäts Frauenklinik, Hôpital Saint-Louis, University Hospital Ulm, Centre Hospitalier Universitaire de Rennes, Université Paris Descartes, Heinrich Heine University Düsseldorf, Institut Curie, Ludwig-Maximilians-Universität München, University of Twente
ORCID: 0000-0001-6933-607X
Observed ORCID: 0000-0001-6933-607X
OpenAlex ID: A5068744991
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
2017 · Sonia S Anand, Jackie Bosch, et al. · The Lancet · 907
PDF
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
2017 · Stuart J Connolly, John W Eikelboom, et al. · The Lancet · 771
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
2016 · Wolfgang J. Janni, Brigitte Rack, et al. · Clinical Cancer Research · 373
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
2022 · Régis Peffault de Latour, Austin Kulasekararaj, et al. · New England Journal of Medicine · 329
PDF
A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma
2009 · Christian Wülfing, Jean‐Pascal H. Machiels, et al. · Cancer · 219
PDF
Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer
2012 · Bas Franken, Marco R de Groot, et al. · Breast Cancer Research · 191
PDF
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial
2022 · Annoek E. C. Broers, Cornelis N. de Jong, et al. · Blood Advances · 139
PDF
Importance of circulating tumor cells in newly diagnosed colorectal cancer
2015 · GUUS VAN DALUM, GERRIT-JAN STAM, et al. · International Journal of Oncology · 113
PDF
Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer
2013 · Sjoerd T. Ligthart, Frank A. W. Coumans, et al. · PLoS ONE · 105
PDF
Circulating tumor cells before and during follow-up after breast cancer surgery
2014 · GUUS VAN DALUM, GERT JAN VAN DER STAM, et al. · International Journal of Oncology · 66
PDF
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome
2021 · Tjerk S.J. Opstal, Aernoud T.L. Fiolet, et al. · Journal of the American College of Cardiology · 63
PDF
Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors
2019 · Cornelis N. De Jong, Ellen Meijer, et al. · Blood · 47
Vaccination responses and lymphocyte subsets after autologous stem cell transplantation
2007 · A.M.T. van der Velden, A.M.E. Claessen, et al. · Vaccine · 43
Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen
2018 · Frédéric Baron, Myriam Labopin, et al. · Clinical Cancer Research · 39
PDF
Effect of N ‐acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial
2017 · Joep W. R. Sins, Karin Fijnvandraat, et al. · British Journal of Haematology · 34
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations
2019 · Kirsten Geneugelijk, Kirsten A. Thus, et al. · Frontiers in Immunology · 31
Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients
2019 · Herman Veenhof, Remco A. Koster, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 31
PDF
Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis
2021 · Sara Hone Lopez, Gursah Kats-Ugurlu, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 24
PDF
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients
2014 · J. J. Zwaginga, B. van der Holt, et al. · Haematologica · 23
PDF
Identification of Two Distinct Mutations at the Same Nucleotide Position, Concomitantly with a Novel Polymorphism in the Vasopressin-Neurophysin II Gene (AVP-NP II) in Two Dutch Families with Familial Neurohypophyseal Diabetes Insipidus
2000 · André P Abbes, Bennie Bruggeman, et al. · Clinical Chemistry · 21
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease
2023 · Pascal M Burger, Jannick A N Dorresteijn, et al. · European Journal of Preventive Cardiology · 20
PDF
Can causes of false-normal D-dimer test [SimpliRED®] results be identified?
2003 · R.A Kraaijenhagen, J Wallis, et al. · Thrombosis Research · 18
HIV infection in critically ill obstetrical patients
2003 · M.R. de Groot, L.J. Corporaal, et al. · International Journal of Gynecology & Obstetrics · 17
PDF
Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune Suppression
2024 · Linde M. Morsink, Carin L.E. Hazenberg, et al. · Transplantation and Cellular Therapy · 13
Non invasive ultrasound measurement of intima-media thickness. A tool to measure early atherosclerosis
1994 · Marco R. de Groot, Jan Dirk Banga · European Journal of Vascular Surgery · 13
Works count: 64
Citation count: 3,750
H-index: 20
I10-index: 29
Year
Topic
Type